By Andrea Shalal, Leah Douglas, Ahmed Aboulenein and Ted Hesson WASHINGTON (Reuters) -Almost half of the probationary workers ...

In a visit to UB, the lawmakers said cutting indirect cost reimbursement for grants would negatively impact livesaving ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

For years Republicans and Democrats alike have touted the medical breakthroughs at Texas medical research institutions like ...

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

The impact will be crippling to biomedical research in the U.S., and institutions will immediately face hard choices about ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

Claiming the cuts are illegal, attorneys general from 22 states, including Rhode Island, on Monday sued the Trump administration, the Department of Health and Human Services, and the National ...

Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...